Luye Pharma Group Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Dian Bo Liu
Chief executive officer
CN¥3.2m
Total compensation
CEO salary percentage | 97.6% |
CEO tenure | 20.8yrs |
CEO ownership | n/a |
Management average tenure | 12.3yrs |
Board average tenure | 9.9yrs |
Recent management updates
Recent updates
Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden
Apr 26Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?
Feb 29Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S
Jan 09Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt
Dec 19A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)
Nov 24Is Luye Pharma Group (HKG:2186) A Risky Investment?
Sep 12Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price
Aug 17Is Luye Pharma Group (HKG:2186) Using Too Much Debt?
May 10We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt
Sep 20Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook
Apr 06Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares
Mar 17A Closer Look At Luye Pharma Group Ltd.'s (HKG:2186) Impressive ROE
Feb 19Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 49% Discount?
Feb 01Is Luye Pharma Group Ltd. (HKG:2186) Popular Amongst Institutions?
Jan 06CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | CN¥533m |
Sep 30 2023 | n/a | n/a | CN¥495m |
Jun 30 2023 | n/a | n/a | CN¥458m |
Mar 31 2023 | n/a | n/a | CN¥531m |
Dec 31 2022 | CN¥3m | CN¥3m | CN¥605m |
Sep 30 2022 | n/a | n/a | CN¥190m |
Jun 30 2022 | n/a | n/a | -CN¥224m |
Mar 31 2022 | n/a | n/a | -CN¥179m |
Dec 31 2021 | CN¥4m | CN¥3m | -CN¥134m |
Sep 30 2021 | n/a | n/a | CN¥210m |
Jun 30 2021 | n/a | n/a | CN¥554m |
Mar 31 2021 | n/a | n/a | CN¥630m |
Dec 31 2020 | CN¥5m | CN¥4m | CN¥707m |
Sep 30 2020 | n/a | n/a | CN¥955m |
Jun 30 2020 | n/a | n/a | CN¥1b |
Mar 31 2020 | n/a | n/a | CN¥1b |
Dec 31 2019 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2019 | n/a | n/a | CN¥1b |
Jun 30 2019 | n/a | n/a | CN¥1b |
Mar 31 2019 | n/a | n/a | CN¥1b |
Dec 31 2018 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2018 | n/a | n/a | CN¥1b |
Jun 30 2018 | n/a | n/a | CN¥1b |
Mar 31 2018 | n/a | n/a | CN¥1b |
Dec 31 2017 | CN¥4m | CN¥3m | CN¥981m |
Compensation vs Market: Dian Bo's total compensation ($USD436.68K) is about average for companies of similar size in the Hong Kong market ($USD552.49K).
Compensation vs Earnings: Dian Bo's compensation has been consistent with company performance over the past year.
CEO
Dian Bo Liu (57 yo)
20.8yrs
Tenure
CN¥3,162,000
Compensation
Mr. Dian Bo Liu is a Co-Founder of Luye Pharma Group Ltd. in 1994 and serves as its Head of Corporate Directions & Strategies and has been its Chief Executive Officer since July 2003. Mr. Liu is responsibl...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 20.8yrs | CN¥3.16m | no data | |
Co-Founder & Vice Executive Chairman | 20.8yrs | CN¥2.87m | no data | |
Co-Founder & Executive Director | no data | CN¥1.47m | no data | |
Executive Director | no data | CN¥1.38m | no data | |
Chief Financial Officer | 12.3yrs | no data | no data | |
Senior Vice President | no data | no data | no data | |
Company Secretary | 3.4yrs | no data | no data |
12.3yrs
Average Tenure
57yo
Average Age
Experienced Management: 2186's management team is seasoned and experienced (12.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 20.8yrs | CN¥3.16m | no data | |
Co-Founder & Vice Executive Chairman | 20.8yrs | CN¥2.87m | no data | |
Co-Founder & Executive Director | 20.8yrs | CN¥1.47m | no data | |
Executive Director | 10.2yrs | CN¥1.38m | no data | |
Independent Non-Executive Director | 9.9yrs | CN¥258.00k | no data | |
Independent Non-Executive Director | 9.9yrs | CN¥309.00k | no data | |
Non-Executive Director | 7.2yrs | CN¥258.00k | no data | |
Independent Non-Executive Director | 9.9yrs | CN¥258.00k | no data | |
Independent Non-Executive Director | 9.9yrs | CN¥258.00k | no data | |
Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data |
9.9yrs
Average Tenure
60yo
Average Age
Experienced Board: 2186's board of directors are considered experienced (9.9 years average tenure).